HIV salvage therapy does not require Nucleoside reverse transcriptase inhibitors a randomized, controlled trial Academic Article uri icon

Overview

MeSH Major

  • Anti-HIV Agents
  • HIV Infections
  • Reverse Transcriptase Inhibitors

abstract

  • National Institute of Allergy and Infectious Diseases, Boehringer Ingelheim, Janssen, Merck, ViiV Healthcare, Roche, and Monogram Biosciences (LabCorp).

publication date

  • December 15, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4681296

Digital Object Identifier (DOI)

  • 10.7326/M15-0949

PubMed ID

  • 26595748

Additional Document Info

start page

  • 908

end page

  • 17

volume

  • 163

number

  • 12